Clinical Sciences
Short-Term Treatment with Metformin Improves the Cardiovascular Risk Profile in First-Degree Relatives of Subjects with Type 2 Diabetes Mellitus who have a Metabolic Syndrome and Normal Glucose Tolerance without Changes in C-Reactive Protein or Fibrinogen
Luis Mauro Alvim de Lima, Nicolas Wiernsperger, Luiz Guilherme Kraemer-Aguiar
, Eliete Bouskela
Corresponding author
Laboratório de Pesquisas Clínica e Experimental em Biologia Vascular (Bio-Vasc), Departamento de Clínica Médica, Centro Biomédico, Universidade do Estado do Rio de Janeiro - Rio de Janeiro/RJ Brazil
Read
970
Timeswas read the article
192
Total PDF
778
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 July | 47 | 13 | 60 |
| 2024 June | 51 | 20 | 71 |
| 2024 May | 57 | 10 | 67 |
| 2024 April | 72 | 11 | 83 |
| 2024 March | 63 | 16 | 79 |
| 2024 February | 36 | 7 | 43 |
| 2024 January | 54 | 13 | 67 |
| 2023 December | 89 | 18 | 107 |
| 2023 November | 31 | 15 | 46 |
| 2023 October | 48 | 24 | 72 |
| 2023 September | 13 | 9 | 22 |
| 2023 August | 16 | 6 | 22 |
| 2023 July | 8 | 7 | 15 |
| 2023 June | 17 | 1 | 18 |
| 2023 May | 36 | 0 | 36 |
| 2023 April | 39 | 1 | 40 |
| 2023 March | 60 | 6 | 66 |
| 2023 February | 14 | 11 | 25 |
| 2023 January | 2 | 2 | 4 |
| 2022 December | 25 | 2 | 27 |
Show all